BioNTech and Pfizer Hope to Have Late-Stage Coronavirus Vaccine Results by October
On Tuesday, BioNTech (NASDAQ: BNTX) confirmed what its big pharma partner, Pfizer (NYSE: PFE), had already let out of the bag: The companies hope to have phase …
Why Value Investing Works
In this episode of Industry Focus: Financials, Jason Moser chats with Motley Fool contributors, Jason Hall and Dan Caplinger about the latest news and earnings …
Why Shares of Movie Theaters and Indoor Entertainment Centers Rallied on Tuesday
What happened COVID-19 has hit indoor entertainment stocks hard, by keeping large crowds from gathering in tight quarters. But Tuesday brought positive news …
Stock Markets Take Late-Day Hit; Inovio, Novavax Plunge on Coronavirus Vaccine Concerns
On Wall Street, it seemed as though Tuesday would be a repeat of Monday, with strength in the Dow Jones Industrial Average (DJINDICES: ^DJI) coupled with …
Why Avis Popped 13% Early Tuesday
What happened Shares of Avis Budget Group (NASDAQ: CAR), a vehicle rental company, jumped over 13% higher Tuesday before giving up some gains in the late …
Nasdaq Falls 186 Points on Tech Rotation; Booking, Expedia Climb on Travel Hopes
The stock market is going through a clear rotation right now, as investors try to position their portfolios to take maximum advantage of what they hope will be …
Why Owens & Minor Stock Just Popped 8%
What happened Shares of medical personal protective equipment (PPE) manufacturer Owens & Minor (NYSE: OMI) are up a strong 7.6% in 3:15 p.m. EDT trading …
Coherus BioSciences Keeps Proving Wall Street Wrong
Coherus BioSciences (NASDAQ: CHRS) had the best-performing drug launch of 2019, doubled revenue in the first half of 2020 compared to the year-ago period, and …
Why Tilray Stock Is Plunging Today
What happened? Shares of Tilray (NASDAQ: TLRY) are down by 13.1% as of 3:22 p.m. EDT on Tuesday, following the company’s release of its second-quarter …
Mesoblast Plunges as FDA Questions Cell-Therapy Manufacturing
Shares of Mesoblast (NASDAQ: MESO) fell as much as 40% today after investors pored over a briefing document for an upcoming advisory committee (AdCom) meeting …